Member Info for JoeyDiamond

As long as he drops an RNS and not another conference call :)

Yes we are the same person because I agreed with their post :)

I'm long term bullish of the company if that annoys your short positions then super :)

For the record I still hold shares at an average of 11p albeight smaller holding now than in the past.

I agree with Munchbox54's post we simply need to see more demand for Vanadium, until then we are running on the spot.

Longer term I do see this company doing well so if SP drops from here I do plan to add to my holdings

As alluded to already we don't know if it order filling / MM's trying to free up stock to hold ready for the next leg up / MM's trying to average out their positions etc.

People need to decide what timeframe they are trading. Short term then buying in at 2.30 wasnt wise if you want to make a quick profit in a few days.

From the investor side you need to have a plan and not just focus on these fluctuations. There has been some excellent posts yesterday on FDA approval / price points / merges / the science etc to give you excellent knowledge of the company and its treatment.

Essentially to come in the near future
Peer review
Various approvals ie FDA
Phase 3 trial
We need a partnership with one of the big boys for supply chain.

Timeframe if all gos well come start September you may be looking at a multion billion company with share price 10 times what it is today around 20 quid. For the long term holders we have patience and don't mind waiting a whilst longer. I base September on Remdisivir took 2-3 days for approval and 25 days for trial to be rushed through.

Yes in the EU and USA

Sorry been away from keyboard im pretty drunk now after Liverpool celebrations so forgive me if i missd anything on the Trump briefing

Donald Trump briefing tonight key points/clues

1) He mentions Operation Warp Speed a fund/grant of 10 billion $ (more if required) to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The following companies are signed up to it Johnson & Johnson (Janssen Pharmaceutical), AstraZeneca-University of Oxford, Pfizer-BioNTech, Moderna, Merck, Vaxart, Inovio, and Novavax.

For the first time he is saying this money will be used to help theraputics research rather than just the vaccines. This is good news as what ever company gets this money will not need to raise funds.

2) He mentions new Theraputics research is very promising, there are new treatments made up of antibody, blood thinners and steroids. Then gos on to say research is doing tremendously well, it even may cure people.

Hmm so this is the fun part
Steroid treament = dexamethasone I suspect
Blood thinners = Could be a number of any but isn't likely to help with lung/viral issues
Antibody = Best guess is monoclonal antibody-based treatments by Regeneron Pharmaceuticals (They were awared $450 million from BARMA the body in Operation Warp Speed)

So a not much for us at Synairgen IMO but the theraputics he alluded too are nothign for us to worry about.

I agree SalaciousC its just so brilliant in its 'simplicity' the Synairgen Professors need to take a bow, they are on the verge of becoming world famous and achieving something truly special.

Thanks Munchbox54 and Dealr

That is some great information here https://bnf.nice.org.uk/medicinal-forms/interferon-beta.html giving price points and dosage sizes.

Yes the key thing im trying to get across is thats its been approved 3 times already by the FDA.

SNG001 should therefore be in theory an easier/quicker one to approve as you have 20 years of data already on it.

So much nonsense written rcently I thought I would share with you all some research I have taken up this afternoon. I have trawled through the database of FDA already approved drugs and cross referenced any that use INTERFERON BETA-1A as an active ingredient.

BOOM!! INTERFERON BETA-1A is already approved for use by FDA just deliveredby other means such as vial/syringe

Drugs already approved as follows

AVONEX
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628

PLEGRIDY
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499

REBIF
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103780

Volume down today compared to previous 2 days so MM's need to do something to generate some action and fill orders.

You can either drop the SP price and scare weak hands into selling or price rises quickly to encourage longer term holders to sell out.

Now we suddenly have a multitude of coordinate crap posts from people who dont hold any stock here saying the end is nigh.

Its amusing to watch

He did buy 3 million shares around April 2016 so a around 20-25p and prob aquired some from Woodford cheap so ye 40p average may be a good guess.

Yes very bold. May be prudent to keep an eye out for what other new ventures he jumps into ;)

Mad to think he just made near 4 million quid but still has the majority of his stock in Synairgen :)

Yes he has top sliced and made a fortune. Had 9.7 million shares and now has 7.7 million. Its notable he has kept the majority of the shares so shows confidence in the treatment and Synairgen story.

If you watched what happened to Hemo or Synairgen after their raises SP went below the placing price. If similar pattern occurs here you looking at 4-5p.

I disagree the amount of uses for Faron in a medical arena will be lessened if SNG001 is proven successful, simply because inhaling it is far superior delivery method.

I hope im wrong for the people investing in FAR but its not one I would be investing in for now.

Required watching IMO if you ghave invested or plan to invest

https://www.youtube.com/watch?v=wqDd7ixh184

I agree with you he normally would want a US company to take credit for the treatment.

However we are 4 months from an election and time is running out. Covid is the big topic voters see as most important in this election.

Perfect scenario for him is a US company partners/buys Synairgen and he can then claim USA is number 1

Following on from last night Trump spoke of a new theraputic coming out very soon.

Obviously we hope he is referring to sng001 but other potential development drugs could be

Gileads remdesivir (inhaled version) or
Revive Therapeutics Bucillamine

Anyone know much about Bucillamine and understands the medical info give an assessment?

Thx